Understand How Markets Actually Work, Learning.Investing.Thriving.

Marc Rudajev

Understand How Markets Actually Work

Learning.Investing.Thriving.

Learning.Investing.Thriving. is built on a simple idea: If you want to build wealth, you need more than stock tips. You need to understand how markets actually work.

Equity Bottom-Up

<ul><li>Oura pulled the deal the day before it was due to list.</li><li>This is not uncommon and happens all the time, but not in the midst of the calmest tape imaginable: a VIX sitting at 15, US major indices at near-record highs, credit default swap (CDS) spreads holding in or narrowing, and a company that had spent a week insisting demand was strong.</li><li>These would generally not lead to postponing an IPO, especially for a company that is profitable, growing, and in an industry (wellness) that has drawn a lot of buzz over the past few years.</li></ul>

Oura pulled the deal the day before it was due to list.This is not uncommon and happens all the time, but not in the midst of the calmest tape imaginable: a VIX sitting at 15, US major indices at near-record highs, credit default swap (CDS) spreads holding in or narrowing, and a company that had spent a week insisting demand was strong.These would generally not lead to postponing an IPO, especially for a company that is profitable, growing, and in an industry (wellness) that has drawn a lot of buzz over the past few years.

Oura IPO Alert: The Market Repriced It Early

US IPOs and Secondary Offerings, IPO Boutique

IPO Boutique

US IPOs and Secondary Offerings

For more than 20 years, we have been providing research, analysis, commentary and ratings on US Equity Capital Markets to institutional investors (US IPOs and Secondary Offerings). Our vast network of contacts across the Equity Capital Markets and attention-to-detail sets us apart from our competitors.

Since 2012, we have achieved a successful hit rating on 89% of Buy-rated IPOs. The collective “Buy” ratings averaged a first trade of 16.3% above issue.Our Neutral Rated Deals averaged just 2% above the issue price at first trade.

Our written research includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

In addition, we provide a high-touch premium desk access which includes analyst access, as well as real time insights on US IPOs as well as secondary offerings.

IPOs and Secondary Offerings

Equity Capital Markets

<ul>
<li>Oura's planned 50 million-share IPO at $40–$44 per share has been postponed, with the company citing market conditions.</li>
<li>Despite a reported multiple-times-oversubscribed book, market conditions and an aggressive valuation step-up contributed to the offering being shelved.</li>
<li>Oura's 5 million paid members and growing subscription business remain central to its investment story, but the timing of a potential IPO remains uncertain.</li>
</ul>


Oura's planned 50 million-share IPO at $40–$44 per share has been postponed, with the company citing market conditions.
Despite a reported multiple-times-oversubscribed book, market conditions and an aggressive valuation step-up contributed to the offering being shelved.
Oura's 5 million paid members and growing subscription business remain central to its investment story, but the timing of a potential IPO remains uncertain.


Oura Inc. (OURA): IPO Postponed Due to Market Conditions

Get Ahead with IPO Insights, IPO Prophet

IPO Prophet

Get Ahead with IPO Insights

At IPO Prophet®, our team leverages over three decades of expertise to deliver actionable quantitative analytics for the IPO market in real-time. This platform synthesizes our extensive experience investing in IPOs, providing investors with revolutionary tools to navigate the complexities of issuance day. Our mission is to empower investors with data-driven insights to make more informed decisions.

<ul>
<li>Two qualifying IPOs are scheduled to price Tuesday and begin trading Wednesday: Oura and Accelevation Holdings.</li>
<li>Together they represent approximately $2.76 billion of base proceeds at midpoint and make this the most consequential new-issue day since the summer window.</li>
<li>The books are constructive. Oura was heard approximately 3x covered before its Boston roadshow, while Accelevation was heard 3–4x covered as of Friday. </li>
</ul>


Two qualifying IPOs are scheduled to price Tuesday and begin trading Wednesday: Oura and Accelevation Holdings.
Together they represent approximately $2.76 billion of base proceeds at midpoint and make this the most consequential new-issue day since the summer window.
The books are constructive. Oura was heard approximately 3x covered before its Boston roadshow, while Accelevation was heard 3–4x covered as of Friday. 


U.S. IPO & Equity Capital Markets Brief 9/28/2026

<ul><li>We have spent the last decade+ turning our lives into a scoreboard. W</li><li>e score our nights, our recovery, our readiness, our steps, our stress (not to mention the social media likes, subscribes, retweets, etc…).</li><li>Apple has led the way for much of this time, both with it’s phones and its watches.</li></ul>

We have spent the last decade+ turning our lives into a scoreboard. We score our nights, our recovery, our readiness, our steps, our stress (not to mention the social media likes, subscribes, retweets, etc…).Apple has led the way for much of this time, both with it’s phones and its watches.

Episode 56: Oura Is a Genuinely Great Business. Its IPO Is a Genuinely Strange Deal.

<ul>
<li>Differentiated health-tech platform: Oura combines wearable technology, biometric data and recurring subscriptions, with approximately 5 million paid members.</li>
<li>Rapid growth: Latest-twelve-month revenue reached approximately $1.43 billion, while paid membership doubled year over year.</li>
<li>Valuation remains a key consideration: The proposed valuation represents a meaningful premium to its October 2025 private financing, despite improving margins and cash generation.</li>
</ul>


Differentiated health-tech platform: Oura combines wearable technology, biometric data and recurring subscriptions, with approximately 5 million paid members.
Rapid growth: Latest-twelve-month revenue reached approximately $1.43 billion, while paid membership doubled year over year.
Valuation remains a key consideration: The proposed valuation represents a meaningful premium to its October 2025 private financing, despite improving margins and cash generation.


Oura Inc. (OURA US): Oura's $14.4 Billion IPO: A Smart Ring With Big Ambitions

United States

Oura Health is a Finnish health technology company best known for creating the Oura Ring, a leading wearable smart ring.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Oura (OURA US)

Oura IPO Alert: The Market Repriced It Early

Oura pulled the deal the day before it was due to list. This is not uncommon and happens all the time, but not in the midst of the calmest tape...

Marc Rudajev

Oura Inc. (OURA): IPO Postponed Due to Market Conditions

Oura's planned $12.8B–$14.4B IPO is on hold despite reported multiple-times oversubscription, as market conditions and valuation concerns...

IPO Boutique

U.S. IPO & Equity Capital Markets Brief 9/28/2026

Period: September 28–October 2, 2026 Coverage: Traditional U.S. operating-company IPOs and consequential ECM transactions of at least $100 million...

IPO Prophet

Episode 56: Oura Is a Genuinely Great Business. Its IPO Is a Genuinely Strange Deal.

We have spent the last decade+ turning our lives into a scoreboard. We score our nights, our recovery, our readiness, our steps, our stress (not to...

Marc Rudajev

Oura Inc. (OURA US): Oura's $14.4 Billion IPO: A Smart Ring With Big Ambitions

Oura brings 5M paid members, rapid revenue growth, recurring subscriptions and 42B hours of biometric data to the IPO market, but at a premium...

IPO Boutique

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)